000 | 01093 a2200301 4500 | ||
---|---|---|---|
005 | 20250518011834.0 | ||
264 | 0 | _c20190812 | |
008 | 201908s 0 0 eng d | ||
022 | _a1525-139X | ||
024 | 7 |
_a10.1111/sdi.12768 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGordon, Craig E | |
245 | 0 | 0 |
_aSummary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease. _h[electronic resource] |
260 |
_bSeminars in dialysis _c03 2019 |
||
300 |
_a187-195 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKidney Transplantation |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xtherapy |
700 | 1 | _aBalk, Ethan M | |
700 | 1 | _aFrancis, Jean M | |
773 | 0 |
_tSeminars in dialysis _gvol. 32 _gno. 2 _gp. 187-195 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/sdi.12768 _zAvailable from publisher's website |
999 |
_c29110620 _d29110620 |